GenMont (3164) Monthly Revenue

Market: TWSE-listed · Industry: Biotech & Medical · 景岳

GenMont (3164) reported revenue of NT$35.4 million for Oct 2026, -4.1% year on year and -22.3% from the previous month. Revenue for Jan–Oct 2026 was NT$331.3 million (-1.8% year on year).

In Oct 2026, it ranked No. 113 by revenue among 160 Biotech & Medical companies.

Monthly revenue chart

Oct 2024 NT$23.5 million24/10Nov 2024 NT$31 millionDec 2024 NT$36.5 millionJan 2025 NT$30.2 millionFeb 2025 NT$25.4 million25/02Mar 2025 NT$43.8 millionApr 2025 NT$39.9 millionMay 2025 NT$28.7 millionJun 2025 NT$43.5 million25/06Jul 2025 NT$31.6 millionAug 2025 NT$26.2 millionSep 2025 NT$31 millionOct 2025 NT$36.9 million25/10Nov 2025 NT$35.2 millionDec 2025 NT$31.3 millionJan 2026 NT$34.5 millionFeb 2026 NT$16.4 million26/02Mar 2026 NT$38.3 millionApr 2026 NT$37.8 millionMay 2026 NT$27.8 millionJun 2026 NT$37.7 million26/06Jul 2026 NT$27.6 millionAug 2026 NT$30.3 millionSep 2026 NT$45.6 millionOct 2026 NT$35.4 million26/10

Hover over (or tap) a bar to see that month’s revenue.

Monthly revenue history

MonthRevenueYoYMoM
Oct 2026NT$35.4 million-4.1%-22.3%
Sep 2026NT$45.6 million+46.9%+50.4%
Aug 2026NT$30.3 million+15.5%+10.0%
Jul 2026NT$27.6 million-12.9%-27.0%
Jun 2026NT$37.7 million-13.2%+35.7%
May 2026NT$27.8 million-3.3%-26.4%
Apr 2026NT$37.8 million-5.4%-1.3%
Mar 2026NT$38.3 million-12.6%+133.2%
Feb 2026NT$16.4 million-35.5%-52.4%
Jan 2026NT$34.5 million+14.1%+10.0%
Dec 2025NT$31.3 million-14.1%-11.0%
Nov 2025NT$35.2 million+13.7%-4.5%
Oct 2025NT$36.9 million+56.9%+18.9%
Sep 2025NT$31 million+23.5%+18.3%
Aug 2025NT$26.2 million-10.7%-17.1%
Jul 2025NT$31.6 million+7.9%-27.2%
Jun 2025NT$43.5 million+59.1%+51.2%
May 2025NT$28.7 million-12.3%-28.0%
Apr 2025NT$39.9 million+6.3%-8.7%
Mar 2025NT$43.8 million+4.6%+72.1%
Feb 2025NT$25.4 million-29.9%-15.9%
Jan 2025NT$30.2 million-13.0%-17.1%
Dec 2024NT$36.5 million+62.8%+17.7%
Nov 2024NT$31 million+32.8%+31.7%
Oct 2024NT$23.5 million-17.2%-6.4%

Jan–Oct 2026 cumulative: NT$331.3 million (-1.8% YoY)

History covers months since this site began collecting, plus prior-month and prior-year figures in each release. It grows every month.

Other Biotech & Medical companies

Compare with peers: GenMont vs PEC / GenMont vs Lotus Pharm / GenMont vs Bora

CompanyRevenueYoY
PEC6446NT$2.84 billion+102.0%
Lotus Pharm1795NT$2.13 billion-22.5%
Bora6472NT$1.99 billion+15.9%
Great Tree Pharmacy6469NT$1.67 billion+1.5%
EXCELSIOR4104NT$1.02 billion+38.6%
PEGAVISION6491NT$793 million+13.0%
Synmosa Biopharma4114NT$766.6 million+41.2%
Y.S.H.3705NT$749.4 million+4.4%

See also

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16